Stem-cell therapy for multiple sclerosis is legally available and regulated in Turkey by the Ministry of Health. High-standard facilities like Medipol Mega University Hospital and NP Istanbul Brain Hospital maintain JCI accreditation. Procedures are generally safe when performed in licensed units following Good Manufacturing Practice (GMP) protocols.
- Regulatory oversight: Clinics must strictly follow the Turkish Ministry of Health regenerative medicine guidelines.
- Safety protocols: Specialized units use advanced air filtration to minimize infection risks during transplants.
- Specialist expertise: Prof. Dr. Erdal Karaöz at Liv Hospital specializes in MS cellular therapy.
- Accreditation standards: Top centers hold JCI and ISO certifications to ensure global quality benchmarks.
Bookimed Expert Insight: Patient volume is a major indicator of institutional expertise in Turkey. Medipol Mega University Hospital serves over 1,000,000 patients annually and manages complex bone marrow transplants. NP Istanbul Brain Hospital is ranked as the second-best brain hospital in Europe. Choosing these high-volume, specialized centers often ensures better access to multidisciplinary teams, including neurologists like Prof. Dr. Sultan Tarlaci who has 25+ years of experience.
Patient Consensus: Patients note that while the treatment is significantly more affordable than in the US, rigorous research into a clinic's specific success data is vital. Many emphasize the helpfulness of personal coordinators in managing the language barrier during complex neurological evaluations.